|
Contact
|
Newsletter
|
Sitemap
|
Deutsch
»
Bayer Group
Home
150 Years of Bayer
Subgroups
Bayer AG (Holding Company)
Bayer HealthCare
Bayer CropScience
Bayer MaterialScience
Bayer Business Services
Bayer Technology Services
Currenta
Topics
Business & Finance
Research & Innovation
Products
Responsible Care
Social Responsibility
Bayer People
Europe
North America
Asia & Pacific
Central-/Latin America
Africa & Middle East
Press Contact
Bayer AG
(Holding Company)
Bayer HealthCare
Bayer CropScience
Bayer MaterialScience
Bayer Business Services
Bayer Technology Services
Photo-Service
Biographies
Board of Management
Subgroup Management Boards
Supervisory Board
Speeches
Photos
Bayer AG (Holding Company)
Bayer HealthCare
Bayer CropScience
Bayer MaterialScience
Bayer Business Services
Bayer Technology Services
Currenta
Education and Training
Research
Locations
Environmental Protection
BayKomm
150 Years of Bayer
TV Service
Bayer AG (Holding Company)
Bayer HealthCare
Animal Health
Consumer Care
Medical Care
Pharmaceuticals
Bayer CropScience
Bayer MaterialScience
Bayer Business Services
Bayer Technology Services
Currenta
Bayer Links
Bayer Global
Bayer HealthCare
Bayer CropScience
Bayer MaterialScience
Bayer Business Services
Bayer Technology Services
Currenta
Special Interest
Investor Relations
Jobs and Career
Foundations
Sports
Culture
Bayer HealthCare
Consumer Care
|
1 - 9
|
Thursday - April 4, 2013
Not intended for US or UK use - AMWC Congress 2013
Bayer’s ATX-101 significantly and sustainably reduces unwanted fat under the chin
90% of patients maintained treatment success in two year follow up / Phase I pharmacokinetic data shows no clinically significant impact on lipid levels / Open-label study data from US trial to be presented at Innovation Session
» more
Friday - February 1, 2013
Not intended for U.S. and UK media - IMCAS Congress 2013
Positive results of Phase-III trials suggest that ATX-101 is effective as a non-surgical treatment for the reduction of unwanted submental fat
» more
Friday - February 1, 2013
Not intended for U.S. and UK media - IMCAS Congress 2013
Positive results of Phase-III trials suggest that ATX-101 is effective as a non-surgical treatment for the reduction of unwanted submental fat
» more
Monday - January 14, 2013
Not intended for US or UK use - JEADV publishes European dermatologists’ call for paradigm shift in acne treatment
Adult female acne requires different treatment from adolescent acne
Consensus has been reached on the treatment of adult female acne / Need to tailor treatment to specific characteristics
» more
Monday - October 1, 2012
Not intended for US or UK use! - Bayer Launches New Mobil Application (APP)
App ‘SKIN PEACE’ advises How to Use Topical Corticosteroid for Eczema Correctly
» more
Friday - September 28, 2012
Not intended for US or UK use! - Atopic Dermatitis: CALM-IT Task Force at EADV 2012
Pruritus Relief within the First Hours after Application of Methyl-prednisolone Aceponate 0.1% to Treat Nickel Sulfate-Induced Eczema
» more
Thursday - September 27, 2012
Not intended for US or UK use! - EADV Congress 2012
International consensus group introduces recommendations and treatment algorithms for hemorrhoidal disease
» more
Thursday - September 27, 2012
Not intended for US or UK use! - EADV Congress 2012
New data suggest an increase in reactive oxygen species in the antibacterial action of isoconazole nitrate
» more
Monday - June 25, 2012
Announcement
Hans-Jörg Weitbrecht Scientific Award 2013
» more
|
1 - 9
|
Copyright @ Bayer AG
General Conditions of Use
-
Privacy Statement
-
Imprint
Print page
Search
Advanced Search
Links
Publications
research – The Bayer Scientific Magazine
Stockholders' Newsletter
Annual Report
Sustainable Development Report
Publications Overview
Newsletter
We will keep you informed about the latest news.
Events
Wednesday, July 31, 2013
Q2 2013 Interim Report
Contact:
Günter Forneck
Additional Press Events
Investor Relations Events
BayKomm Events
Download Center - Selection
Your selection:
0
Download(s)